Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat
β Scribed by Jiri Kovarik; Dominique Chabannes; Jean F. Borel
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 653 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The gliotic scar in the demyelinated plaque is a prominent feature of the pathology of multiple sclerosis. Chronic relapsing experimental allergic encephalomyelitis (EAE) in the SJL/J mouse has many characteristics in common with multiple sclerosis in the human, including the development of intense
Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats\* Experimental allergic encephalomyelitis (EAE) is an inflammatory disease of the central nervous system (CNS). Among the leukocytes which infiltrate the CNS during EAE, numerous macrophag
## Abstract Magnetic resonance imaging detects bloodβbrain barrier disruption after gadoliniumβDTPA enhancement of central nervous system lesions of multiple sclerosis. Experimental allergic encephalomyelitis has many clinical and pathological features in common with multiple sclerosis including al
To evaluate the immunomodulating activity of methionine-enkephalin (Met-Enk) and leucine-enkephalin (Leu-Enk) in the development of experimental allergic encephalomyelitis (EAE), two strains of rats, one highly susceptible to EAE (Lewis rats) and the other relatively resistant to the disease (Wistar